Saturday, February 14, 2026
ADVT 
International

UK PM Johnson to visit India on April 21 to strengthen ties

Darpan News Desk, 20 Apr, 2022 10:45 AM
  • UK PM Johnson to visit India on April 21 to strengthen ties

UK Prime Minister Boris Johnson will pay an official visit to India from April 21-22. This will be his maiden visit to India as Prime Minister, said the Ministry of External Affairs on Sunday.

During the two-day meet, the British Prime Minister will first land in Ahmedabad on April 21 and then proceed to Delhi.

The ministry statement said, "At the invitation of Prime Minister Shri Narendra Modi, the Rt. Hon'ble Boris Johnson MP, Prime Minister of the United Kingdom will pay an official visit to India from 21-22 April 2022. This will be his maiden visit to India as Prime Minister of the United Kingdom."

During the visit, Prime Minister Narendra Modi and the UK PM are likely to discuss trade, defence and the Ukraine crisis.

"The Prime Ministers will review implementation of the Roadmap 2030 and set their vision for further intensifying cooperation across the full spectrum of bilateral ties. They will also exchange views on regional and global issues of mutual interest," said the ministry.

"Prime Minister Johnson will be accorded a ceremonial welcome at Rashtrapati Bhavan and will hold bilateral consultations with the Prime Minister on April 22. Besides official engagements in New Delhi, the Prime Minister of the United Kingdom will also visit Gujarat on April 21.

"India and the United Kingdom enjoy a long and historical relationship which was elevated to a Comprehensive Strategic Partnership during the India-UK Virtual Summit in 2021," said the ministry in a statement.

MORE International ARTICLES

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine